Viewing Study NCT00100750


Ignite Creation Date: 2025-12-24 @ 5:18 PM
Ignite Modification Date: 2026-03-14 @ 1:20 PM
Study NCT ID: NCT00100750
Status: COMPLETED
Last Update Posted: 2015-01-13
First Post: 2005-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Breast Carcinoma View
None Stage IV Breast Cancer View
Keywords: